1,356
Views
8
CrossRef citations to date
0
Altmetric
Commentary

Pentavalent vaccine

A major breakthrough in India’s Universal Immunization Program

, , , , , & show all
Pages 1314-1316 | Received 26 Apr 2012, Accepted 05 May 2012, Published online: 16 Aug 2012

References

  • Ministry of health and family welfare. Immunization handbook for medical officers. New Delhi: Government of India, 2009.
  • Registrar General of India. Provisional Population Totals Paper 1 of 2011 India Series 1. New Delhi: Office of the Registrar General and Census Commissioner of India, 2011.
  • Registrar General of India. Sample registration system: measures of fertility and mortality in India. New Delhi: Government of India, 2011.
  • Sharma S. Immunization coverage in India. New Delhi: Institute of Economic Growth; 2007. Working paper series No. E/283/2007.
  • International Institute of Population Sciences. NFHS-1, 1992-93. Summary of findings. Mumbai;IIPS, 1995.
  • International Institute of Population Sciences. ORC Macro. NFHS-2, 1998-99. Summary of findings. Mumbai:IIPS, 2000.
  • International Institute for Population Sciences. Reproductive and Child Health. District Level Household Survey (DLHS-2) 2002-04 India. Mumbai:IIPS, 2006.
  • International Institute for Population Sciences. District Level Household and Facility Survey 200708. Mumbai:IIPS, 2010.
  • UNICEF. Coverage Evaluation Survey, 2009. All India Report. New Delhi: UNICEF, 2010. Available from: http://www.unicef.org/india/National_Fact_Sheet_CES_2009.pdf.
  • Shea B, Andersson N, Henry D. Increasing the demand for childhood vaccination in developing countries: a systematic review. BMC Int Health Hum Rights 2009; 9:Suppl 1 S5; http://dx.doi.org/10.1186/1472-698X-9-S1-S5; PMID: 19828063
  • Nakayama T, Aizawa C, Kuno-Sakai H. A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids. J Allergy Clin Immunol 1999; 103:321 - 5; http://dx.doi.org/10.1016/S0091-6749(99)70508-7; PMID: 9949325
  • Halsey NA. Limiting infant exposure to thimerosal in vaccines and other sources of mercury. JAMA 1999; 282:1763 - 6; http://dx.doi.org/10.1001/jama.282.18.1763; PMID: 10568650
  • Available from. . http://www.gavialliance.org/support/nvs/hib/
  • Available from. . http://www.unicef.org/supply/files/8._DTP-containing_vaccines_including_pentavalent_and_hexavalent.pdf
  • Minz S, Balraj V, Lalitha MK, Murali N, Cherian T, Manoharan G, et al. Incidence of Haemophilus influenzae type b meningitis in India. Indian J Med Res 2008; 128:57 - 64; PMID: 18820360
  • Watt JP, Wolfson LJ, O’Brien KL, Henkle E, Deloria-Knoll M, McCall N, et al, Hib and Pneumococcal Global Burden of Disease Study Team. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet 2009; 374:903 - 11; http://dx.doi.org/10.1016/S0140-6736(09)61203-4; PMID: 19748399
  • Singhi P, Bansal A, Geeta P, Singhi S. Predictors of long term neurological outcome in bacterial meningitis. Indian J Pediatr 2007; 74:369 - 74; http://dx.doi.org/10.1007/s12098-007-0062-6; PMID: 17476082
  • Kabra SK, Kumar P, Verma IC, Mukherjee D, Chowdhary BH, Sengupta S, et al. Bacterial meningitis in India: an IJP survey. Indian J Pediatr 1991; 58:505 - 11; http://dx.doi.org/10.1007/BF02750932; PMID: 1800332
  • Chinchankar N, Mane M, Bhave S, Bapat S, Bavdekar A, Pandit A, et al. Diagnosis and outcome of acute bacterial meningitis in early childhood. Indian Pediatr 2002; 39:914 - 21; PMID: 12428036
  • Invasive Bacterial Infections Surveillance (IBIS) Group of the International Clinical Epidemiology Network. Are Haemophilus influenzae infections a significant problem in India? A prospective study and review. Clin Infect Dis 2002; 34:949 - 57; http://dx.doi.org/10.1086/339327; PMID: 11880961
  • Das BK, Arora NK, Mathur P, Ostwal P, Mandal S, Kabra SK, et al. Nasopharyngeal carriage of Haemophilus influenzae. Indian J Pediatr 2002; 69:775 - 7; http://dx.doi.org/10.1007/BF02723690; PMID: 12420910
  • Verma R, Khanna P, Prinja S, Rajput M, Chawla S, Bairwa M. Hepatitis B Vaccine in national immunization schedule: a preventive step in India. Hum Vaccin 2011; 7:1387 - 8; http://dx.doi.org/10.4161/hv.7.12.17878; PMID: 22134433
  • Sharma HJ, Yadav S, Lalwani SK, Kapre SV, Jadhav SS, Chakravarty A, et al. Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children. Hum Vaccin 2011; 7:451 - 7; http://dx.doi.org/10.4161/hv.7.4.14208; PMID: 21403463
  • Bavdekar SB, Maiya PP, Subba Rao SD, Datta SK, Bock HL. Immunogenicity and safety of combined diphtheria tetanus whole cell pertussis hepatitis B/ Haemophilus influenzae type b vaccine in Indian infants. Indian Pediatr 2007; 44:505 - 10; PMID: 17684303
  • Ali SS, Chandrashekar SR, Singh M, Bansal RK, Sharma DR, Arora D. A multicenter, prospective, open-label, non-comparative study to evaluate the immunogenicity and tolerance of a new, fully liquid pentavalent vaccine (DTwP-HepB-Hib vaccine). Hum Vaccin 2007; 3:116 - 20; http://dx.doi.org/10.4161/hv.3.4.4061; PMID: 17617743
  • Rao R, Dhingra MS, Bavdekar S, Behera N, Daga SR, Dutta AK, et al. A comparison of immunogenicity and safety of indigenously developed liquid (DTwPHB-Hib) pentavalent combination vaccine (Shan 5) with Easyfive (liq) and TritanrixHB + Hiberix (lyo) in Indian infants administered according to the EPI schedule. Hum Vaccin 2009; 5:425 - 9; PMID: 19333002
  • Chatterjee S, Rego SJ, D’Souza F, Bhatia BD, Collard A, Datta SK, et al. The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule. BMC Infect Dis 2010; 10:298; http://dx.doi.org/10.1186/1471-2334-10-298; PMID: 20950457
  • Subcommittee on Introduction of Hib Vaccine in Universal Immunization Program, National Technical Advisory Group on Immunization, India. NTAGI subcommittee recommendations on Haemophilus influenzae type B (Hib) vaccine introduction in India. Indian Pediatr 2009; 46:945 - 54; PMID: 19955578
  • Nair H, Hazarika I, Patwari A. A roller-coaster ride: Introduction of pentavalent vaccine in India. J Glob Health 2009; 1:32 - 5
  • Gupta M, Prinja S, Kumar R, Kaur M. Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India. Health Policy Plan. 2012 Mar 8. [Epub ahead of print]
  • Government of India. Meeting of the National Technical Advisory Group on Immunization 16 June, 2008 – Minutes and Recommendations. New Delhi: Government of India, 2008.
  • Press Information Bureau, Government of India. http://pib.nic.in/newsite/erelease.aspx?relid=79191. English Release 17-April 2012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.